Adhezion Biomedical Receives FDA Marketing Clearance For SurgiSeal™ Topical Skin Adhesive New Topical Skin Adhesive Is Cleared For U.S. Launch

Posted on Thursday, January 8th, 2009 and is filed under Health Care. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Adhezion Biomedical LLC, a medical device manufacturer, announced that the FDA has provided marketing clearance for its SurgiSeal (2-octyl cyanoacrylate) topical skin adhesive. SurgiSeal is the first and only 2-octyl cyanoacrylate that does not require an activator. It is indicated for use in surgical and emergency applications.